ArticleAssessment of PD-L1 and p53 expression in urinary bladder carcinoma: Association with different clinicopathologic characteristics
ArticleAssessment of PD-L1 and p53 expression in urinary bladder carcinoma: Association with different clinicopathologic characteristics
ArticleHigh expression of the checkpoint molecule PD-1 on regulatory and helper CD4+ T cells in metastatic breast cancer patients with poor prognosis
ArticleHigh expression of the checkpoint molecule PD-1 on regulatory and helper CD4+ T cells in metastatic breast cancer patients with poor prognosis
ArticlePredictive and Prognostic Impact of Tumor-Infiltrating Lymphocytes (CD8+) In Breast Cancer Treated With Neoadjuvant Chemotherapy
ArticlePredictive and Prognostic Impact of Tumor-Infiltrating Lymphocytes (CD8+) In Breast Cancer Treated With Neoadjuvant Chemotherapy
ArticleEffect of neoadjuvant chemotherapy on circulating immune cells in breast cancer patients: A pilot study
ArticleEffect of neoadjuvant chemotherapy on circulating immune cells in breast cancer patients: A pilot study
ArticleImmunohistochemical expression of programmed death-ligand 1 (PD-L1) in invasive duct carcinoma of the breast of no special type and correlation with patients' clinicopathological
ArticleImmunohistochemical expression of programmed death-ligand 1 (PD-L1) in invasive duct carcinoma of the breast of no special type and correlation with patients' clinicopathological
ArticleAnalysis of the cellular expression of checkpoint molecules on immune cells in patients with breast cancer: Thesis Abstract
ArticleAnalysis of the cellular expression of checkpoint molecules on immune cells in patients with breast cancer: Thesis Abstract
ArticleThe Expression of Immune Checkpoint Inhibitors PDL-1 and CTLA-4 in Pancreatic Versus Non-Pancreatic Periampullary Adenocarcinoma: An Immunohistochemical Study
ArticleThe Expression of Immune Checkpoint Inhibitors PDL-1 and CTLA-4 in Pancreatic Versus Non-Pancreatic Periampullary Adenocarcinoma: An Immunohistochemical Study